Advantage Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-9,053
| Closed | -$34K | – | 1107 |
|
|
2018
Q2 | $34K | Sell |
9,053
-83,492
| -90% | -$314K | 0.02% | 440 |
|
|
2018
Q1 | $379K | Buy |
92,545
+13,369
| +17% | +$54.8K | 0.14% | 118 |
|
|
2017
Q4 | $368K | Buy |
79,176
+5,997
| +8% | +$27.9K | 0.11% | 126 |
|
|
2017
Q3 | $520K | Buy |
73,179
+2,542
| +4% | +$18.1K | 0.17% | 101 |
|
|
2017
Q2 | $511K | Buy |
70,637
+4,947
| +8% | +$35.8K | 0.18% | 99 |
|
|
2017
Q1 | $405K | Buy |
65,690
+10,934
| +20% | +$67.4K | 0.16% | 107 |
|
|
2016
Q4 | $321K | Buy |
54,756
+9,596
| +21% | +$56.3K | 0.12% | 113 |
|
|
2016
Q3 | $240K | Buy |
45,160
+2,598
| +6% | +$13.8K | 0.09% | 124 |
|
|
2016
Q2 | $282K | Buy |
42,562
+124
| +0.3% | +$822 | 0.13% | 112 |
|
|
2016
Q1 | $198K | Buy |
42,438
+9,936
| +31% | +$46.4K | 0.08% | 128 |
|
|
2015
Q4 | $164K | Sell |
32,502
-565
| -2% | -$2.85K | 0.09% | 151 |
|
|
2015
Q3 | $116K | Buy |
33,067
+22,358
| +209% | +$78.4K | 0.07% | 192 |
|
|
2015
Q2 | $107K | Buy |
10,709
+309
| +3% | +$3.09K | 0.05% | 230 |
|
|
2015
Q1 | $132K | Buy |
+10,400
| New | +$132K | 0.07% | 183 |
|